Medical Weight Management Programme

Doctor-supervised, personalised weight loss programme led by senior consultant gastroenterologists. Addresses obesity and metabolic conditions including fatty liver, diabetes, and cardiovascular risk through clinical assessment, nutrition planning, and targeted medical interventions.

AliveoMedical's medical weight management programme is a structured, clinically-guided pathway designed for individuals who need more than generic diet advice. The programme is led by four senior consultant gastroenterologists — Dr Chua Tju Siang (SCOPE-certified by the World Obesity Federation), Dr Stephen Tsao Kin Kwok, Dr Lee Keat Hong, and Dr Loo Wai Mun — who collectively bring decades of experience in obesity, metabolic, and digestive medicine. The programme begins with a comprehensive initial medical evaluation, reviewing the patient's medical history, current health status, lifestyle factors, and risk profile. Blood tests and digestive screening (gastroscopy, fibroscan) may be ordered to understand how weight interacts with other health markers such as liver enzyme levels, fasting glucose, HbA1c, and lipid fractions. Where indicated, a dietitian is involved to develop a practical, sustainable nutrition plan tailored to the patient's medical profile and daily routine — not a generic calorie-restriction diet. Medical interventions are considered on a case-by-case basis: these may include prescription appetite suppressants, fat-blockers, or GLP-1 receptor agonist medications. Endoscopic procedures such as gastric balloon placement are available for eligible patients seeking non-surgical intervention. Regular follow-up consultations are a core feature of the programme, with scheduled reviews to monitor key health indicators (BMI, liver enzymes, blood sugar, lipids), evaluate progress, and adjust the plan. AliveoMedical explicitly positions this as a medical — not cosmetic — service, targeting individuals whose weight poses a clinical risk. The programme is particularly suited to patients with fatty liver disease, pre-diabetes, type 2 diabetes, sleep apnoea, GERD, or elevated cardiovascular risk markers. Dr Chua Tju Siang's SCOPE certification from the World Obesity Federation distinguishes the team's formal training in obesity medicine.